RxDoctor Payments Data

John Adams, DO

General Practice · Plain City, OHNPI 1487603601

Payments from drug & device makers

$2,127in general payments, 2019–2025

Across 170 payments — averaging $12.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$804
  • Novo Nordisk$219
  • Amarin Pharma, Inc.$139
  • AstraZeneca$137
  • Merck$96
  • Astellas Pharma US Inc$93
  • plus $639 from 17 others

What the payments were for

  • Food & beverage$2,06597%
  • Education$623%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,127 in reported general payments places this provider in the 90th percentile of 2,933 general practice providers in Ohio.

See all general practice providers in Ohio

Medicare billing

Part B allowed, 2024
$43,205
Medicare patients
155
Services billed
500

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban111$88,038
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69$47,980
JanuviaSitagliptin Phosphate38$33,435
JardianceEmpagliflozin24$27,093
MyrbetriqMirabegron50$24,738
XareltoRivaroxaban24$21,346
LinzessLinaclotide31$16,899
Tresiba Flextouch U-200Insulin Degludec21$16,808
TradjentaLinagliptin21$12,472
InvokanaCanagliflozin16$12,454
Breo ElliptaFluticasone/Vilanterol23$12,360
VascepaIcosapent Ethyl19$10,526
AbrysvoRsv Vacc, Pref A And Pref B/Pf20$6,263
Celecoxib45$6,239
Advair HfaFluticasone Propion/Salmeterol12$5,967

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo$84$94,300131 claims
GSKTrelegy Ellipta, Breo Ellipta$25$60,34192 claims
Boehringer IngelheimJardiance, Tradjenta$29$39,56545 claims
Johnson & JohnsonXarelto, Invokana$63$33,80040 claims
MerckJanuvia$96$33,43538 claims
Astellas Pharma US IncMyrbetriq$93$24,73850 claims
AbbVieLinzess, Synthroid$804$19,41774 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$5,79613 claims
AstraZenecaBrilinta$137$5,52712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,933 general practice providers in Ohio.

Other general practice in Plain City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →